Astria Therapeutics, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.21M-0.98M-0.84M0.50M-0.10M
Gross Profit -0.21M-0.98M-0.84M0.50M-0.10M
Operating items
Research & Development 13.99M15.69M23.03M25.45M18.68M17.04M
Selling, General & Administrative 4.12M6.00M8.63M10.11M8.91M9.33M
Operating Expenses 18.12M21.68M31.66M35.56M27.59M26.37M
Operating Income -18.12M-21.68M-31.66M-35.56M-27.09M-26.37M
EBIT -18.12M-21.68M-31.66M-35.56M-27.09M-26.37M
Non-operating items
Interest & Investment Income 0.24M0.16M0.42M
Other Non Operating Income 0.00M0.00M0.01M0.09M0.03M0.18M
Non Operating Income 0.00M-0.20M-0.97M-0.50M-0.27M0.50M
Net income details
EBT -18.12M-21.89M-32.64M-36.15M-27.40M-26.05M
Profit After Tax -18.12M-21.88M-32.63M-36.06M-27.36M-25.87M
Income from Continuing Operations -18.12M-21.89M-32.64M-36.15M-27.40M-26.05M
Consolidated Net Income -18.12M-21.89M-32.64M-36.15M-27.40M-26.05M
Income towards Parent Company -18.12M-21.89M-32.64M-36.15M-27.40M-26.05M
Net Income towards Common Stockholders -18.12M-21.89M-32.64M-36.15M-27.40M-26.05M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.25M0.31M0.38M1.18M1.97M3.35M13.01M16.83M36.30M56.43M
EBITDA -18.12M-21.68M-31.66M-35.56M-27.09M-26.37M